Financial Penalties, COVID-19 Liability Top FDLI List Of Top Medtech Lawsuits
The report outlines the lawsuits that the Food and Drug Law Institute believes could have the greatest impacts on industries regulated by the US FDA.
You may also be interested in...
High court’s decision that FTC lacks authority to seek monetary recovery in litigation is boon for drug makers who have been subject to hefty payouts in reverse settlement and other cases brought by the commission.
The decision limits US FDA discretion in determining how to regulate products that seem to meet both drug and device standards.
The sentences are the latest chapter in a long-running off-label marketing case.